SEC Form 4 · accession 0001209191-15-078115
Minerva Neurosciences, Inc. · NERV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Kupfer
Director
Period of report
Nov 2, 2015
Accepted (ET)
Nov 3, 2015 · 4:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001598646
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1,F2 | $5.41 | Nov 2, 2015 | A | 25,000 | A | — | Nov 1, 2025 | Common Stock | 25,000 | 25,000 | D |
Explanation of responses
- F1The price is the closing price of the Issuer's common stock on November 2, 2015.
- F2These shares shall vest quarterly over 3 years beginning November 2, 2015.